EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and In Vitro and In Silico Evaluation of 1,3,4‐Oxadiazoles as Anti‐ Trypanosoma cruzi and Anti‐ Leishmania mexicana Agents

Timoteo Delgado-Maldonado, Adriana Moreno-Rodríguez, Luis D González-Morales, Any Laura Flores-Villegas, Jorge Rodríguez-González, Lorena Rodríguez-Páez, Charmina Aguirre-Alvarado, Luis M Sánchez-Palestino, Eyra Ortiz-Pérez, Gildardo Rivera iD

ChemMedChem · 2024

DOI: 10.1002/cmdc.202400241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Timoteo Delgado-Maldonado und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, 88710, Reynosa, México. Hauptthemen laut MEDLINE: Oxadiazoles, Trypanosoma cruzi, Leishmania mexicana, Drug Design. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Secretaria de Investigación y Posgrado del Instituto Politécnico Nacional.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of novel 4‐acetyl‐1,3,4‐oxadiazole derivatives was designed and synthesized for their biological evaluation in vitro against Trypanosoma cruzi ( T. cruzi ) and Leishmania mexicana ( L. mexicana ). Additionally, all compounds were evaluated by molecular docking on the cruzain of T. cruzi ( Tc Cz) and the cysteine protease B (CPB) of L. mexicana ( Lm CPB) to know their potential mechanism of binding. Compound OX‐12 had better trypanocidal activity against NINOA (IC 50 =10.5 μM) and A1 (IC 50 =21.7 μM) T. cruzi strains that reference drug benznidazole (IC 50 =30.3 μM and 39.8 μM, respectively). Compound OX‐2 had the best biological activity against L. mexicana in M379 (IC 50 =11.9 μM) and FCQEPS (IC 50 =34.0 μM) strains that the reference drug glucantime (IC 50 >120 μM). All the compounds showed important interactions with residues on the active site of Tc Cz (Gly66, Trp26, Leu67, and Ala138) and Lm CPB (Gly67, Asn62, Leu68, and Ala140). Finally, the molecular dynamics simulations of the compound OX‐12 shown moderate stability from 40–115 ns with an RMSD value of 6.5 Å. Meanwhile, compound OX‐2 showed a minor stability in complex with CPB from 25–200 ns of simulation (RMSD

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxadiazolesTrypanosoma cruziLeishmania mexicanaDrug DesignTrypanocidal AgentsMolecular Docking SimulationParasitic Sensitivity TestsStructure-Activity RelationshipMolecular StructureDose-Response Relationship, DrugAntiprotozoal AgentsProtozoan Proteins

Stichwörter der Autor:innen

1,3,4-OxadiazolesChagas diseasesLeishmaniasisMolecular dockingMolecular dynamics

Substanzen

OxadiazolesTrypanocidal Agents1,3,4-oxadiazoleAntiprotozoal AgentsProtozoan Proteins

Autor:innen und Institutionen

  • Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, 88710, Reynosa, México.
  • Laboratorio de Estudios Epidemiológicos, Clínicos, Diseños Experimentales e Investigación, Facultad de Ciencias Químicas, Universidad Autónoma "Benito Juárez" de Oaxaca, Avenida Universidad S/N, Ex Hacienda Cinco Señore…
  • Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Ciudad Universitaria, 04510, Coyoacán, Ciudad de México, México.
  • Departamento de Bioquímica, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, 11340, Ciudad de México, México.

ORCID-Profile: Gildardo Rivera

Förderung

  • Secretaria de Investigación y Posgrado del Instituto Politécnico Nacional

Zitieren

APA

Delgado-Maldonado, T., Moreno-Rodríguez, A., González-Morales, L. D., Flores-Villegas, A. L., Rodríguez-González, J., Rodríguez-Páez, L., Aguirre-Alvarado, C., Sánchez-Palestino, L. M., Ortiz-Pérez, E., & Rivera, G. (2024). Design, Synthesis, and In Vitro and In Silico Evaluation of 1,3,4‐Oxadiazoles as Anti‐ Trypanosoma cruzi and Anti‐ Leishmania mexicana Agents. ChemMedChem. https://doi.org/10.1002/cmdc.202400241

Vancouver

Delgado-Maldonado T, Moreno-Rodríguez A, González-Morales LD, Flores-Villegas AL, Rodríguez-González J, Rodríguez-Páez L, et al. Design, Synthesis, and In Vitro and In Silico Evaluation of 1,3,4‐Oxadiazoles as Anti‐ Trypanosoma cruzi and Anti‐ Leishmania mexicana Agents. ChemMedChem. 2024. doi:10.1002/cmdc.202400241

BibTeX
@article{DelgadoMaldonado2024,
  author = {Delgado-Maldonado, Timoteo and Moreno-Rodríguez, Adriana and González-Morales, Luis D and Flores-Villegas, Any Laura and Rodríguez-González, Jorge and Rodríguez-Páez, Lorena and Aguirre-Alvarado, Charmina and Sánchez-Palestino, Luis M and Ortiz-Pérez, Eyra and Rivera, Gildardo},
  title = {Design, Synthesis, and In Vitro and In Silico Evaluation of 1,3,4‐Oxadiazoles as Anti‐ Trypanosoma cruzi and Anti‐ Leishmania mexicana Agents},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202400241}
}
Kostenlos starten →